28. Contrast agents for myocardial perfusion studies Mechanisms, state oj the art and future prospects
暂无分享,去创建一个
[1] S. Kaul,et al. Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of regional myocardial perfusion. , 1988, Journal of the American College of Cardiology.
[2] S. Feinstein,et al. Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility. , 1987, The American journal of cardiology.
[3] S. Kaul,et al. Myocardial contrast echocardiography in humans: I. Safety--a comparison with routine coronary arteriography. , 1986, Journal of the American College of Cardiology.
[4] R. Yoon,et al. Zeta-potential measurements on microbubbles generated using various surfactants , 1986 .
[5] S. Powsner,et al. Automated production and analysis of echo contrast agents. , 1986, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[6] T. Fritzsch,et al. Myocardial perfusion defects in contrast echocardiography: spatial and temporal localisation. , 1986, Ultrasound in medicine & biology.
[7] S. Meerbaum. Promise and status of myocardial contrast-enhanced two-dimensional echocardiography: delineation of ischemic risk zone and quantitation of myocardial perfusion defects. , 1986, Journal of the American College of Cardiology.
[8] J. Roelandt,et al. Myocardial perfusion imaging in humans by contrast echocardiography using polygelin colloid solution. , 1985, Journal of the American College of Cardiology.
[9] L. Teichholz,et al. Generating precision microbubbles for use as an echocardiographic contrast agent. , 1985, Journal of the American College of Cardiology.
[10] A. Parisi,et al. Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. , 1984, Circulation.
[11] M. André,et al. Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs. , 1984, The American journal of cardiology.
[12] O. L. Kwan,et al. Superior intensity and reproducibility of SHU-454, a new right heart contrast agent. , 1984, Journal of the American College of Cardiology.
[13] D. Sahn,et al. Ultrasonic contrast studies for the detection of cardiac shunts. , 1984, Journal of the American College of Cardiology.
[14] M. Matsuda,et al. [Contrast echocardiography of the left heart by intravenous injection of perfluorochemical emulsion]. , 1983, Journal of cardiography.
[15] J. D’Arrigo. Biological surfactants stabilizing natural microbubbles in aqueous media , 1983 .
[16] R. Kloner,et al. Hydrogen peroxide contrast--enhanced two-dimensional echocardiography: real-time in vivo delineation of regional myocardial perfusion. , 1983, Circulation.
[17] R. Peshock,et al. Hydrogen peroxide contrast echocardiography. , 1983, The American journal of cardiology.
[18] D. Yount. A model for microbubble fission in surfactant solutions , 1983 .
[19] U. Losert,et al. Myocardial perfusion evaluated by contrast echocardiography. A preliminary report. , 1982, Chest.
[20] E. G. Tickner,et al. Assessment of Myocardial Perfusion Abnormalities with Contrast‐enhanced Two‐dimensional Echocardiography , 1982, Circulation.
[21] P. Serruys,et al. Intravenous carbon dioxide as an echocardiographic contrast agent , 1981, Journal of clinical ultrasound : JCU.
[22] E. G. Tickner,et al. Gelatin encapsulated nitrogen microbubbles as ultrasonic contrast agents. , 1980, Investigative radiology.
[23] E. G. Tickner,et al. The source of ultrasound contrast effect , 1980, Journal of clinical ultrasound : JCU.
[24] X. F. Wang,et al. Contrast echocardiography with hydrogen peroxide. II. Clinical application. , 1979, Chinese medical journal.
[25] H. Feigenbaum,et al. Intracavitary echoes in patients with mitral prosthetic valves , 1975, Journal of clinical ultrasound : JCU.
[26] Felix Sebba,et al. Microfoams—an unexploited colloid system , 1971 .
[27] E. Carstensen,et al. Ultrasonic detection of cavitation at catheter tips. , 1970, The American journal of roentgenology, radium therapy, and nuclear medicine.
[28] M. Ziskin,et al. Ultrasonic detection of in-vivo cavitation and pressure effects of high-speed injections through catheters. , 1969, Investigative radiology.
[29] R. Gramiak,et al. Echocardiography of the aortic root. , 1968, Investigative radiology.
[30] D. Adams,et al. Cavitation at catheter tips: a possible cause of air embolus. , 1968, Investigative radiology.
[31] G. Race,et al. Removal of Cholesterol and Other Lipids From Experimental Animal and Human Atheromatous Arteries By Dilute Hydrogen Peroxide , 1966, Angiology.
[32] G E BURCH,et al. The use of intracardiac carbon dioxide in the diagnosis of pericardial disease. , 1961, American heart journal.
[33] H. M. Stauffer,et al. In vivo visualization of intracardiac structures with gaseous carbon dioxide; cardiovascular-respiratory effects and associated changes in blood chemistry. , 1956, The American journal of physiology.
[34] G. W. Willard. Ultrasonically Induced Cavitation in Water: A Step‐by‐Step Process , 1953 .
[35] E. Corday,et al. Effects of intracoronary administered echo-contrast agents on epicardial coronary flow, ECG, and global and regional hemodynamics , 1987 .
[36] R. Meltzer,et al. Effect of viscosity on the size of microbubbles generated for use as echocardiographic contrast agents , 1986 .
[37] E. G. Tickner,et al. The Source of Echocardiographic Contrast , 1982 .
[38] P. Serruys,et al. Transmission of ultrasonic contrast through the lungs. , 1981, Ultrasound in medicine & biology.
[39] E. G. Tickner,et al. Why do the lungs clear ultrasonic contrast? , 1980, Ultrasound in medicine & biology.